🇺🇸 FDA
Pipeline program

PCSK9 inhibitor (PCSK9i)

WestChinaH-CVD-009

Unknown small_molecule active

Quick answer

PCSK9 inhibitor (PCSK9i) for Coronary Artery Disease is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Coronary Artery Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials